• Scientific rationale

    The webinar will be focused on the therapeutic management of Head and Neck cancers, with particular regards to the current evidences and future development of particle therapy. . Particle therapy is currently one of the advanced techniques of radiation therapy, increasingly selected thanks to the advantageous physical and biological properties.. Due to the proximity of HNC target volumes to numerous critical structures and the radioresistance of several histologies, nowadays hadrontherapy represents a promising alternative to photon-based therapy. Head and Neck cancers treatment needs a multidisciplinary approach due to the complexity and rarity of the disease.
    In this setting, future perspectives will explore the possible combination of systemic therapies and Hadrontherapy, defining the role and timing of these new strategies within national and international collaboration.

  • Programme

    15.00

     Meeting Introduction

    		Ester Orlandi
    15.10

    Current evidence of protons and future developments for H&N cancers

    		Arnaud Beddok
    15.30

    Proton therapy for nasopharyngeal carcinoma

    		Melvin Chua Lee Kiang
    15.50

    CNAO experience for H&N cancers

    		Sara Ronchi, Barbara Vischioni
    16.10

    Hadrontherapy for paranasal sinuses cancers

    		Juliette Thariat
    16.30

    Challenges in combining endoscopic surgery and particle therapy for paranasal sinuses cancers

    		Marco Ferrari
    16.50

    Combining hadrons and chemotherapy or immunotherapy for rare H&N cancers: state of the art and future challenges

    		Laura Locati
    17.10

    Discussion

    17.25

    Take home messages

    		Ester Orlandi
    17.30

    Adjourn

  • Registration

    This course is reserved to a limited number of participants.

    Participation in this course is free of charge.

    Completing the online registration is mandatory to attend this course.

  • CME Instructions

    The credit certification for the webinar is subject to:

    - Professions/specializations should correspond to those which have been accredited for CME
    - attendance at the live webinar on the platform fad.accmed.org;
    - the completion of the Meeting evaluation online form;
    - completion of the final test (at least 75% of correct answers). 5 attempts admitted. The test and the meeting evaluation form must be completed within 3 days from the end of the event.

  • Training objective

    Contenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica, ivi incluse le malattie rare e la medicina di genere

  • Report Qualità